Interest for ayurvedic healthcare items increments in the midst of COVID-19 emergency Kumar Jeetendra | April 30, 2020 In the midst of the coronavirus flare-up, the interest for ayurvedic items with medical advantages and invulnerability building characteristics has expanded the country over, Business Standard has detailed. As indicated by the report, organizations like Dabur and Himalaya Wellness said they have seen an expansion sought after for ayurvedic items across portfolios. The interest for …
Demand for Laboratory Filtration Technologies High Due to Rising Need for Quality Control in Industries Kumar Jeetendra | August 3, 2020 While quality control is an important aspect for almost all industries, the level of quality control for some particular industries, such as pharmaceuticals, life sciences, and food & beverages, has to be absolutely top-notch. It is quite obvious that these industries deal with crucial elements, and, if not handled properly, serious damage to human health …
Alembic Pharma gets USFDA’s’ speculative endorsement for type 2 diabetes DRUG Kumar Jeetendra | August 29, 2020 In a regulatory filing, Alembic Pharmaceuticals said it has received tentative approval by the US Food and Drug Administration (USFDA) for both Empagliflozin and Linagliptin pills in the strengths of 10 mg/5 mg and 25 mg/5 mg. Alembic Pharma stated it is now in litigation with Boehringer at District Court of Delaware and launch of …
Lupin dispatches generic rheumatoid arthritis drug in US market Kumar Jeetendra | September 2, 2020 Medicine manufacturer Lupin on Wednesday said it has established Leflunomide pills, used to treat rheumatoid arthritis, even in the US marketplace. The business has established the product in 10 mg and 20 mg strengths after receiving the approval by the US Food and Drug Administration (USFDA) before, Lupin said in a statement. The item could …
Innovations Assist Compound Management in Pharma Drug Discovery Kumar Jeetendra | September 10, 2020 Ziath has released a module to enable their Mirage, Cube or Express tube readers to decode Brooks Acoustix tubes. Acoustix is a small sample tube with a screw cap which is increasingly favored for storage of novel compounds in solution in large compound stores. It is also compatible with the latest generation of Labcyte Echo …
GlaxoSmithKline CEO hopeful COVID-19 immunization generally accessible in 2021 Kumar Jeetendra | September 30, 2020 The chief executive of GlaxoSmithKline, the world’s largest maker of vaccines, said she was convinced that the industry will have the ability to make an immunisation against COVID-19 widely available next year. “I share the optimism that we’ll have solutions next year. The challenge here is getting into the scale that’s required,” GSK CEO Emma …
Compact, High Resolution Chromatography Flowmeter Kumar Jeetendra | October 9, 2020 TESTA Analytical Solutions e.K. has developed a new flowmeter which enables continuous measurement of flow rate without interference in chromatography systems. Flow rate is one of the most important parameters in any liquid chromatography system, it determines retention time or volume and has by nature a major influence on reproducibility. Compatible with all HPLC and …
Dr Reddy’s gets 3 perceptions from USFDA for US-based API plant Kumar Jeetendra | March 10, 2021 Dr Reddy’s Laboratories on Wednesday said the US health regulator has issued a Form 483 with three observations after inspecting its Production facility in Middleburg, New York. The audit of the business’s active pharmaceutical ingredients (API) manufacturing plant at Middleburg, New York has been completed from the US Food and Drug Administration (USFDA), the Hyderabad-based …
AstraZeneca COVID-19 immunization connected with little risk of low blood platelets: Study Kumar Jeetendra | June 10, 2021 The Oxford-AstraZeneca vaccine, known in India as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK. The increased risk of the condition, known as idiopathic thrombocytopenic purpura (ITP), is estimated to be 11 per million doses, similar …
Cipla launches initiative to improve access to nebulisers for acute asthma management in primary health care centres of rural India Kumar Jeetendra | December 10, 2021 Mumbai, 10th December 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced a first-of-its-kind initiative to improve access to nebulization therapy specifically for patients in the rural sections of the country. With Cipla’s unmatched presence across the care continuum and a wide range of drug-device combinations and treatments, the …
Pharmaceutical Roots: Justicia Adhatoda – from ancient medicine to novel drug candidate Kumar Jeetendra | February 6, 2023 Pharmaceutical Roots is a content series from LGC Mikromol investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their uses, risks, and mechanisms of action. Introduction It’s been used for thousands of years in Indian and European medicine and also formed the basis of modern drugs for coughs, colds …
Pharmaceutical Roots: etoposide – the winding road from folk remedy to chemotherapy drug Kumar Jeetendra | August 9, 2023 Etoposide is a leading chemotherapy drug used widely in cancer treatment – but in particular against testicular and small cell lung cancer, which together account for more than 400,000 new cases worldwide each year. Although sourced from a plant used to treat many ailments for centuries, its development as an antineoplastic drug was “very tortuous” …